The California Institute for Regenerative Medicine (CIRM) is launching a loan programme that aims to help private biotechnology companies while providing a funding stream for the institute. The programme is expected to be approved this week by the board that oversees CIRM, although major specifics are still undecided, including the amount of money involved.
That raises the question of how comfortable the public will be with committing CIRM funds to one of the riskiest fields of a risky sector. Two types of loan will be awarded -recourse loans,
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LHC meltdown before first collision
A mechanical failure has shut down the world's largest particle accelerator for at least two months.
The Large Hadron Collider (LHC), a US$4.1-billion machine located at CERN, Europe's particle-physics laboratory near Geneva, Switzerland, will be out of commission possibly until early next year to allow repairs to be made to a section of superconducting cable that is thought to have melted during a test on 19 September, just nine days after the collider circulated its first beams.
"We've had better days, " says James Gillies, CERN's chief spokesperson.
The LHC is designed to accelerate protons to energies of 7 teraelectronvolts before smashing them together. To keep the beam focused and fast, the machine depends on around 9,600 superconducting niobium-titanium magnets. The magnets must be kept at temperatures of just 1.9 kelvin while carrying roughly 10,000 amps. The magnets carry this enormous load without generating heat, but if a section of the niobium-titanium rises above its operating temperature it can lead to a catastrophic failure known as a 'quench' .
That is exactly what seems to have happened as physicists passed 8,000 amps into a sector of the LHC's 27-kilometre underground ring. A cable feeding current between two of the LHC's beam-focusing quadrupole magnets suddenly heated to above superconducting temperatures and melted. The failure seems to have happened at a joint where two sections of cable were spliced together. Tens of thousands of joints run around the LHC and many of them had already been tested without incident.
The failure caused the liquid helium that was being used to cool the magnets to boil off, apparently rupturing the machine and releasing as much as a tonne of the gas into the LHC tunnels. During testing the tunnels are evacuated and no injuries were reported.
Such failures are not uncommon during the early commissioning of an accelerator, Gillies says. "With a normally conducting machine you could fix it in a couple of days. " But the LHC's superconducting status also makes it difficult to service. To fix the broken sector, physicists must heat thousands of tonnes of magnets from near-absolute-zero to room temperature, make the necessary repairs, and then slowly cool the system back down. Just warming and cooling will take at least two months, Gillies says.
The setback has dashed the hopes of thousands of researchers working on the four main detectors that will use the LHC. They had hoped to get their first data from proton-proton collisions as early as this week, but it now
The shutdown may be due to a welding failure. Human-produced antibodies could also be used as a research tool, says Antonio Lanzavecchia of the Institute for Research in Biomedicine in Bellinzona, Swizerland. "I really believe this approach is going to be the major pathway to new vaccines," he says.
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Heidi Ledford seems unlikely that collisions will occur this year. CERN normally shuts down during the winter months to save on electricity costs, says Tommaso Dorigo, a physicist at the CERN's Compact Muon Solenoid detector. He and others think the repairs will run into that winter shutdown. "I'm not sure collisions are going to happen in 2008, " Dorigo says.
That doesn't mean physicists will be sitting on their hands in the coming months. Much must still be done to prepare the detectors for first collisions, according to Pauline Gagnon, a senior scientist on CERN's ATLAS detector. Physicists must still calibrate the hundreds of thousands of sub-detectors in each of the larger experiments, and that can be done with high-energy cosmic rays from outer space rather than beam from the machine. "It would be easier with the beam, but we can still do it, " Gagnon says.
But for graduate students trying to complete their theses, there is no substitution for the real thing. Fresh data are imperative, especially for the American contingent, according to Seth Zenz, a graduate student at the University of California, Berkeley, who is currently working on ATLAS. Without new data, Zenz explains, he can't complete his thesis, and he is now planning on spending seven years in graduate school instead of six. Still, Zenz says, he's willing to put up with the delays: "I can wait a few more months before getting back to affordable sushi and burritos in California, " he says.
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which must be paid back, and non-recourse loans, which do not have to be paid back if a product's development ends. CIRM is guaranteed a stake in the recipient company worth 10% of the loan's value for a recourse loan, or 100% for a non-recourse loan. The loans come with other strings -for instance, a requirement to provide California with any developed product at a state-approved price.
Greg Bonfiglio, managing partner of Palo Alto-based Proteus Venture Partners, which focuses on regenerative medicine, estimates that roughly 700 companies around the world are working in the field, and many are in California, where the loan funds must be spent. So there is already a market for the loans, he says.
What will determine biotech's response -and CIRM's potential windfall -will be their assessment of the trade-offs involved in accepting CIRM money: "It's really about the terms -that's where the rubber meets the road," Bonfiglio says.
■ Erika Check Hayden "Infectious-disease research has come full circle."
